Nile Therapeutics, Inc. (NASDAQ: NLTX) will be making a presentation at the BIO 12th Annual CEO and Investor Event. The company's CRO, Joshua Kazam, will host their presentation at the event. The company has been scheduled to deliver their presentation on February 8th at 9:00am (EST). The conference is being held in NYC at The Waldorf Astoria Hotel in the Duke of Windsor Room.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
